Out-of-hospital cardiac arrest (OHCA) treatment developer Avive Solutions announced today that it closed a $22 million Series A financing round.
San Francisco-based Avive develops an intelligent automated external defibrillator (AED) and connected response platform. The company will use the funding to advance its AED platform.
Avive’s offering integrates the Avive Connect AED — which awaits FDA approval — with its proprietary, data-driven emergency response software platform, all of which seamlessly connects with 911 emergency communications centers through a partnership with RapidSOS, according to a news release.
The platform offers incident data-sharing capabilities to providers with the aim of closing data gaps that often exist during cardiac arrest response. Emergency communications centers with access to RapidSOS can dispatch Avive Connect AEDs to the location of a cardiac arrest emergency by audibly alerting and displaying a map on the device to navigate bystanders to the location of the person in cardiac arrest.
Avive said it designed the system to reduce time to defibrillation and increase the likelihood of AEDs being used before emergency medical services arrive, which can potentially increase survival rates.
“Avive is changing the paradigm of response to cardiac arrest emergencies through our connected platform,” Avive Co-Founder and CEO Sameer Jafri said in the release. “By getting life-saving AED technology in the hands of bystanders who can provide immediate help when and where it’s needed, and facilitating closer collaboration with emergency responders and healthcare providers, we believe our vision for a more streamlined system of care can greatly improve the odds of survival.”
Questa Capital, Catalyst Health Ventures and repeat investor Laerdal Million Lives Fund led the Series A financing round. Questa Founder and Managing Partner Ryan Drant, along with Catalyst Managing Partner Darshana Zaveri, both joined Avive’s board in connection with the financing.